Page last updated: 2024-10-27

gentamicin and Cardiometabolic Syndrome

gentamicin has been researched along with Cardiometabolic Syndrome in 1 studies

Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ibraheem, ZO1
Basir, R1
Aljobory, AKh1
Ibrahim, OE1
Alsumaidaee, A1
Yam, MF1

Other Studies

1 other study available for gentamicin and Cardiometabolic Syndrome

ArticleYear
Impact of gentamicin coadministration along with high fructose feeding on progression of renal failure and metabolic syndrome in Sprague-Dawley rats.
    BioMed research international, 2014, Volume: 2014

    Topics: Animals; Blood Glucose; Body Weight; Disease Progression; Drug Combinations; Fructose; Gentamicins;

2014